Objective: TransientHIV infectionshavebeeninvokedtoaccountfor thecellular immune responses detected in highly virus-exposed individuals who have remained HIV-seronegative. We tested for very low levels of HIV RNA in 524 seronegative plasma samples from 311 highly exposed women and men from three longitudinal HIV cohorts.
Introduction
Anti-HIV cellular immune responses have been reported in some highly HIV-exposed but consistently seronegative individuals leading to the possibility that particularly effective early cellular immunity might, on rare occasion, eliminate HIV infections [1] [2] [3] [4] [5] [6] [7] [8] . The presence of HIV viral nucleic acids was also reported in blood collected over 12 months prior to seroconversion [9, 10] and very low levels of HIV proviral DNA were reported in two highly HIV exposed, consistently seronegative male homosexuals [11] . Low-dose simian immunodeficiency virus (SIV) mucosal challenges in macaques have also lead to apparently transient low-level viremia months prior to the establishment of chronic viremia and seroconversion [12] [13] [14] [15] [16] . The continued presence of very low levels of SIV proviral DNA in peripheral blood mononuclear cells (PBMCs) years following inoculation in seronegative macaques suggests a smoldering infection [17] . Transient or persistent low-level HIV or SIV replication in the absence of seroconversion might therefore reflect particularly effective innate or cellular immune responses, infections with highly attenuated HIV strains, and/or host genetic restrictions on sustained viral replication.
Detailed investigations of transient viremia reported in newborns indicated a lack of satisfactory documentation for these infections [18, 19] . Some of the highly exposed seronegative individuals with detectable cellular immune response were subsequently shown to undergo seroconversion, indicating against a long-term protective effect [2, 20] . To test for the occurrence of transient viremia we tested seronegative plasma samples from highly exposed individuals in three HIV infection cohorts for very low levels of HIV RNA. PBMCs from potentially viremic cases were then analyzed for proviral HIV DNA.
Material and methods

San Francisco Men's Health Study
All tests were approved by the UCSF committee on human research. The San Francisco Men's Health Study (SFMHS) was a prospective study of high-risk gay men sampled from 1985 to 1995 [21] . Seronegative SFMHS participants were identified at the time points when they reported engaging in receptive anal intercourse with the greatest number of partners (>3 insertive partners or >1 insertive partner without condom in prior months). Plasma from seroconverters was also selected for analysis at serial time points before and at seroconversion.
San Francisco City Clinic Cohort
This longitudinal cohort of gay and bisexual men treated for sexually transmitted infections at the San Francisco City Clinic (SFCCC) was initiated in 1978 [22, 23] . We identified samples from timepoints between 1983 and 1985 from men who reported the highest-risk behavior as determined by a risk score incorporating number of partners and proportion of sex acts involving unprotected anal receptive sex with ejaculation in the past 4 months.
Women Interagency Health Study
Plasma samples from seronegative women with the most exposure to HIV (sex with known HIV-infected partner, number of partners, unprotected anal sex) were tested [24] .
Transcription-mediated amplification assay
The primary assay used for the detection of low-level HIV RNA was the isothermal transcription-mediated amplification or TMA (APTIMA HIV RNA qualitative assay; Gen-Probe San Diego, California, USA). The TMA assay was FDA-approved as a qualitative test to screen blood donations for HIV RNA and has been approved for clinical use. TMA has a sensitivity of 5.0 copies RNA/ml (50% limit of detection) or 13 copies RNA/ml (95% limit of detection) when testing 0.5 ml of plasma [25] [26] [27] . When plasma volume was sufficient we tested multiple 0.5-ml aliquots per time point (average 3.95, range 2-6). The use of TMA in quadruplicate assay (using 4 Â 0.5 ml plasma) improved the limit of detection to below 3.5 HIV RNA copies/ml [28] . A TMA signal/ cut-off (S/CO) ratio greater than 1.0 is considered a positive signal. At low viral loads a direct relationship has been observed between rising S/CO ratios from 1.0 to 20 and rising viral loads [28, 29] . Above 100 HIV RNA/ml the S/CO is saturated [28, 29] .
Human genetic polymorphisms test
Twelve PCR assays targeting polymorphic human chromosome sites in which insertion/deletion differences are frequently observed were used as described [30] .
Proviral DNA nested PCR Genomic DNA was extracted from thawed frozen PBMC using the QIAamp DNA blood kit (Qiagen). A nested PCR (nPCR) targeting the HIV gag p17 region was used with 400 ng of PBMC genomic DNA as input. The PCR primers and conditions are as described except that primer PG6 was replaced by 5 0 -acttttacccatgcatttaaagttctaggt-3 0 [11] . Using plasmid pNL43 dilutions containing 3, 10, 50, 100 copies as input, the nested PCR was performed in quadruplicates. The sensitivity of the nPCR was estimated using agarose gel electrophoresis at 3-10 HIV DNA copies in the presence of 1 mg of human genomic DNA.
Results and discussion
HIV RNA testing of plasma from three cohorts A total of 196 seronegative plasma samples from 133 individuals (122 nonseroconverters and 11 seroconverters) 620 AIDS 2011, Vol 25 No 5 from the SFMHS were tested for low-level HIV RNA using 921 TMA assays (Table 1) . Additionally, nine HIV antibody-positive plasma samples from individuals who had seroconverted within the previous 6 months (i.e. prior bleed was seronegative) were also tested. The nine seropositive plasma samples were all strongly HIV RNA-positive, with all TMA replicate tests yielding S/ CO values of above 15. Plasma samples from 11 seronegative individuals who seroconverted during the following 6 months (i.e. were seropositive at the subsequent bleed) were included among the 196 seronegative samples. Two of these 11 individuals were found to be in their primary HIV-infection phase with similarly strong HIV RNA-positive signals in all TMA replicate assays. In contrast none of the 25 samples collected more than 6 months prior to seroconversion in these 11 individuals were viremic.
The 122 highly exposed nonseroconverters from the SFMHS were also tested using multiple replicate TMA tests per sample. All samples except one were TMAnegative in all replicate assays (S/CO < 1). A single sample had one out of five TMA replicate assays with a positive S/CO of 2.0 (SFMHS 50320). In order to further assess the viremic nature of this sample collected in February 1986, 8 ml of additional plasma from the same individual and time point was tested using 16 TMA replicate assays. All 16 replicate TMA assays were negative.
Of the 42 seronegative plasma samples provided from 42 San Francisco City Clinic Cohort (SFCCC) participants tested using 109 replicate TMA assays only one was HIV RNA positive (SFCCC 5093) ( A total of 136 seronegative women in the Women Interagency Health Study (WIHS) with the most exposure to HIV were selected. Two hundred and eighty-six plasma samples from the time points when exposure was highest for these individuals were then tested using 1043 TMA assays ( Table 1) . Seven of 286 plasma samples yielded positive TMA test results. Five of the positive plasma samples were from the time points collected immediately prior to seroconversion, and therefore represented typical primary HIV infection (in these 5 cases 4/4 replicate TMA were strongly positive with S/CO >15). The other two samples were from women who did not seroconvert at the subsequent bleed. These two samples had very low-level HIV RNA reactivity, in both cases only one out of four replicate TMA assays were positive with low S/CO of 1 to 2 (WIHS 60101030, 20204650). Further plasma aliquots from these two individuals at the same time points were acquired and re-analyzed by replicate TMA assays. None of four replicate TMA tests run on each of these two samples were positive.
Negative proviral DNA testing of cases with possible transient viremia
In order to test for the presence of proviral DNA in the three potentially transiently infected patients we used a nested PCR protocol targeting the gag region.
PBMCs were not available from the same time point as the weakly TMA-positive 1986 plasma sample from SFMHS participant 50320. PBMC collected at two time points in 1989, when the participant was still seronegative, were therefore selected for HIV proviral DNA No HIV viremia in highly exposed individuals Delwart et al. 621 From a total of 524 seronegative plasma samples collected from 311 highly exposed men and women, only four samples showed any evidence of HIV RNA more than 6 months prior to seroconversion. One case was the consequence of a sample mix-up. In the remaining three cases only a single out of four or five replicate TMA assays were positive and then only with very low-level S/CO ratios. Further replicate TMA testing of more plasma failed to yield any positive results. Because very low levels HIV proviral DNA might represent an archive of a past transient infection [11, 17] we tested these three patients for proviral DNA using nPCR. No PBMC proviral reservoirs were detected.
Our negative results indicate that if transient viremia occurs, it must be either at levels too low to be reproducibly detected and/or of too short duration to have been sampled in the plasma tested here. It also remains conceivable that in some instances viral replication is restricted near mucosal surfaces or in draining lymphoid tissues and therefore not able to reach detectable plasma levels [31] [32] [33] [34] . Alternatively the cellular immune responses reported in highly exposed seronegatives may be due to their continued exposure to non-infectious HIV proteins rather than to viral replication.
